Medical News

RSS

Breast milk should not be stored and fed later

The levels of the components in breast milk change every 24 hours in response to the needs of the baby. A new study published in the journal Nutritional Neuroscience shows, for example, how this milk could help newborn babies to sleep.

3 Oct 2009

BMI training course launched by Anthem Blue Cross to tackle childhood obesity

In a continued effort to keep screening for childhood obesity at the forefront, Anthem Blue Cross' State Sponsored Business launched an innovative on-line Body Mass Index (BMI) training course featuring a virtual BMI wheel and web-based interactive practice sessions to help provide hands-on experience.

3 Oct 2009

$1 million grant to expand health insurance coverage to uninsured children

The Health Research and Educational Trust of New Jersey, an affiliate of the New Jersey Hospital Association, has been awarded a grant of nearly $1 million under a federal program aimed at expanding health insurance coverage to uninsured children.

3 Oct 2009

New flu emergency website launched

United Way of Southeastern Pennsylvania has launched a new regional website geared towards helping families, individuals and organizations find up-to-date information on where to go for H1N1 and seasonal influenza shots and other critical news regarding the seasonal flu epidemics expected to hit the region.

3 Oct 2009

Budget cuts to affect low-income seniors

An 81-year-old San Francisco woman with dementia, little money and an equally aged caregiver sister who is suffering from cancer.

3 Oct 2009

Health reform unlikely to fix Medicare doctor payment system

Health care reform in Congress is unlikely to reform the Medicare physician payment system, and lawmakers are likely to settle for another one-year fix to block a reduction in payments to doctors, CQ Politics reports.

3 Oct 2009

Phase 1b clinical trial results of PEG-Interferon lambda to be presented

Bristol-Myers Squibb Company and ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that final results from a Phase 1b clinical trial in patients with hepatitis C (HCV) treated with PEG-Interferon lambda, a new class of interferon, in combination with ribavirin will be presented at the American Association for the Study of Liver Diseases (AASLD) annual meeting October 30–November 3, 2009, in Boston.

3 Oct 2009

Google's venture capital wing invests in biotech company

Google's venture capital group is investing millions into Adimab, a biotech company that will construct a massive library of antibodies, some of which may yield powerful new drugs, the New York Times blog Bits reports.

3 Oct 2009

EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine

Baxter International Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) granted its “positive opinion” for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. This positive opinion confirms the acceptability of Baxter’s regulatory submission to obtain final marketing authorization and licensure of the product.

From Baxter International Inc. 3 Oct 2009

Americans are not getting correct drug information, says study

Do consumers truly understand how to take their medications and the possible side effects and interactions that can occur as a result? Though the vast majority of study respondents who have recently picked up a prescription drug say they understand how to take their medication (90%), only 60% are aware of the potential interactions with other prescribed medication, and only 58% are aware of interactions with OTC medication they are taking, according to the latest ‘Under the Skin’ survey by ORC Guideline, an infoGROUP company.

3 Oct 2009

A-Life Hospital to demonstrate Actus at the 81st AHIMA Convention

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today that A-Life Hospital, its wholly owned subsidiary, will exhibit and present at the upcoming 81st American Health Information Management Association (AHIMA) Convention and Exhibit.

3 Oct 2009

CSIRO research on grains and lamb to develop new dietary sources of omega-3 oils

CSIRO research on grains and lamb aimed at developing new dietary sources of long-chain omega-3 oils will be presented at the World Congress on Oils and Fats in Sydney this week.

3 Oct 2009

ETEX' Equivabone receives additional FDA clearance for use in posterolateral spine fusion

ETEX Corporation, an advanced biomaterials company, announced today additional FDA 510(k) cleared indications for EquivaBone®. EquivaBone was the first FDA cleared hard-setting osteoinductive material and is the only osteoinductive bone graft substitute that provides a continuous nanocrystalline calcium phosphate scaffold.

3 Oct 2009

First U.S. patients could receive H1N1 vaccine next week

U.S. health officials announced Thursday the first batches of the H1N1 (swine flu) vaccine the government ordered will begin arriving in designated locations across the country on Tuesday and may be administered in the first patients by the end of next week, Reuters reports (Fox, 10/1).

3 Oct 2009

Finance's marathon markup complete as senators look forward to panel vote and floor action

Senators finished amending the Senate Finance Committee's health reform draft early Friday morning. The next stop after the panel's final vote early next week is the Senate floor.

3 Oct 2009

Update from BioCryst Pharmaceuticals regarding antiviral peramivir

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Office of the Secretary, Department of Health & Human Services (HHS) has issued "HHS Secretary's Declaration for the Use of the Public Readiness and Emergency Preparedness Act for the Influenza Antiviral Peramivir."

3 Oct 2009

Nutra Pharma manufactures first commercial batch of Cobroxin

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has completed manufacturing the first commercial batch of Cobroxin and has successfully released it for final distribution.

3 Oct 2009

FDA grants Fast Track designation to Corthera's relaxin for treating acute heart failure

Corthera Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to relaxin, the company's investigational drug for the treatment of acute heart failure (AHF). The Fast Track program facilitates the development and expedites the review of new drugs intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs.

3 Oct 2009

Eye treatment reimbursement change could cost Medicare millions

A change in the reimbursement rate for the drug Avastin, used off-label to treat an eye illness in the elderly, could lead Medicare doctors to use a much costlier drug that would cost the system millions, The New York Times reports.

3 Oct 2009

Telik's announces positive results from Phase 1-2a TELCYTA-carboplatin-paclitaxel combination study

Telik, Inc. today announced the publication of the positive results from a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination with carboplatin and paclitaxel as first-line therapy for patients with nonsmall cell lung cancer (NSCLC) in a leading peer reviewed publication, the Journal of Thoracic Oncology, October 2009; Vol. 4, No. 10.

3 Oct 2009